# Ridgepost Capital, Inc.: financial statements, quarterly

RPC · NYSE · CIK 1841968 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rpc.md) · [Financials](/companies/rpc/financials.md) · [Filings](/companies/rpc/filings.md) · [Insiders](/companies/rpc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rpc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [58.9](/filings/0000950170-24-123725.md) | [63.1 d](/filings/0001193125-26-081484.md) | [66.1](/filings/0000950170-25-067201.md) | [71.1](/filings/0000950170-25-105611.md) | [74.2](/filings/0001193125-25-272253.md) | [85.0 d](/filings/0001193125-26-081484.md) | [67.7](/filings/0001193125-26-213908.md) | [72.7](/filings/0001193125-26-340176.md) | [75.9](/filings/0001193125-25-272253.md) | [81.0 d](/filings/0001193125-26-081484.md) | [75.0](/filings/0001193125-26-213908.md) | [80.9](/filings/0001193125-26-340176.md) |
| Operating income | $m | [0.4](/filings/0000950170-24-123725.md) | [5.3 d](/filings/0001193125-26-081484.md) | [12.1](/filings/0000950170-25-067201.md) | [16.8](/filings/0000950170-25-105611.md) | [8.8](/filings/0001193125-25-272253.md) | [22.9 d](/filings/0001193125-26-081484.md) | [11.2](/filings/0001193125-26-213908.md) | [17.7](/filings/0001193125-26-340176.md) | [10.7](/filings/0001193125-25-272253.md) | [25.9 d](/filings/0001193125-26-081484.md) | [19.6](/filings/0001193125-26-213908.md) | [17.7](/filings/0001193125-26-340176.md) |
| Interest expense | $m | [5.5](/filings/0000950170-24-123725.md) | [5.8 d](/filings/0001193125-26-081484.md) | [5.8](/filings/0000950170-25-067201.md) | [6.1](/filings/0000950170-25-105611.md) | [6.7](/filings/0001193125-25-272253.md) | [6.9 d](/filings/0001193125-26-081484.md) | [6.4](/filings/0001193125-26-213908.md) | [6.8](/filings/0001193125-26-340176.md) | [7.0](/filings/0001193125-25-272253.md) | [7.1 d](/filings/0001193125-26-081484.md) | [6.4](/filings/0001193125-26-213908.md) | [6.6](/filings/0001193125-26-340176.md) |
| Income tax | $m | [1.8](/filings/0000950170-24-123725.md) | [1.8 d](/filings/0001193125-26-081484.md) | [1.8](/filings/0000950170-25-067201.md) | [3.7](/filings/0000950170-25-105611.md) | [1.3](/filings/0001193125-25-272253.md) | [2.0 d](/filings/0001193125-26-081484.md) | [0.3](/filings/0001193125-26-213908.md) | [1.4](/filings/0001193125-26-340176.md) | [1.1](/filings/0001193125-25-272253.md) | [6.7 d](/filings/0001193125-26-081484.md) | [4.0](/filings/0001193125-26-213908.md) | [2.4](/filings/0001193125-26-340176.md) |
| Net income | $m | [(8.4)](/filings/0000950170-24-123725.md) | [(1.1) d](/filings/0001193125-26-081484.md) | [5.0](/filings/0000950170-25-067201.md) | [7.0](/filings/0000950170-25-105611.md) | [1.4](/filings/0001193125-25-272253.md) | [5.3 d](/filings/0001193125-26-081484.md) | [4.5](/filings/0001193125-26-213908.md) | [3.4](/filings/0001193125-26-340176.md) | [2.1](/filings/0001193125-25-272253.md) | [9.5 d](/filings/0001193125-26-081484.md) | [8.5](/filings/0001193125-26-213908.md) | [7.3](/filings/0001193125-26-340176.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0000950170-24-123725.md) | not reported | [0.04](/filings/0000950170-25-067201.md) | [0.06](/filings/0000950170-25-105611.md) | [0.01](/filings/0001193125-25-272253.md) | not reported | [0.04](/filings/0001193125-26-213908.md) | [0.03](/filings/0001193125-26-340176.md) | [0.02](/filings/0001193125-25-272253.md) | not reported | [0.08](/filings/0001193125-26-213908.md) | [0.06](/filings/0001193125-26-340176.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0000950170-24-123725.md) | not reported | [0.04](/filings/0000950170-25-067201.md) | [0.06](/filings/0000950170-25-105611.md) | [0.01](/filings/0001193125-25-272253.md) | not reported | [0.04](/filings/0001193125-26-213908.md) | [0.03](/filings/0001193125-26-340176.md) | [0.02](/filings/0001193125-25-272253.md) | not reported | [0.08](/filings/0001193125-26-213908.md) | [0.07](/filings/0001193125-26-340176.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.0](/filings/0000950170-24-123725.md) | [30.5](/filings/0001193125-26-081484.md) | [29.0](/filings/0000950170-25-067201.md) | [31.2](/filings/0000950170-25-105611.md) | [61.5](/filings/0001193125-25-272253.md) | [67.5](/filings/0001193125-26-081484.md) | [74.4](/filings/0001193125-26-213908.md) | [33.4](/filings/0001193125-26-340176.md) | [40.0](/filings/0001193125-25-272253.md) | [28.2](/filings/0001193125-26-340176.md) | [29.0](/filings/0001193125-26-213908.md) | [36.6](/filings/0001193125-26-340176.md) |
| Total assets | $m | [815](/filings/0000950170-23-063085.md) | [834](/filings/0000950170-25-030098.md) | [833](/filings/0000950170-24-056908.md) | [823](/filings/0000950170-24-094357.md) | [857](/filings/0000950170-24-123725.md) | [869](/filings/0001193125-26-081484.md) | [877](/filings/0000950170-25-067201.md) | [932](/filings/0000950170-25-105611.md) | [936](/filings/0001193125-25-272253.md) | [928](/filings/0001193125-26-340176.md) | [910](/filings/0001193125-26-213908.md) | [1,153](/filings/0001193125-26-340176.md) |
| Total liabilities | $m | [387](/filings/0000950170-23-063085.md) | [409](/filings/0000950170-25-030098.md) | [433](/filings/0000950170-24-056908.md) | [426](/filings/0000950170-24-094357.md) | [463](/filings/0000950170-24-123725.md) | [482](/filings/0001193125-26-081484.md) | [503](/filings/0000950170-25-067201.md) | [543](/filings/0000950170-25-105611.md) | [539](/filings/0001193125-25-272253.md) | [525](/filings/0001193125-26-340176.md) | [506](/filings/0001193125-26-213908.md) | [636](/filings/0001193125-26-340176.md) |
| Long-term debt | $m | [262](/filings/0000950170-23-063085.md) | [290](/filings/0000950170-25-030098.md) | [314](/filings/0000950170-24-056908.md) | [301](/filings/0000950170-24-094357.md) | [319](/filings/0000950170-24-123725.md) | [320](/filings/0001193125-26-081484.md) | [373](/filings/0001193125-26-213908.md) | [373](/filings/0000950170-25-105611.md) | [393](/filings/0001193125-25-272253.md) | [373](/filings/0001193125-26-340176.md) | [375](/filings/0001193125-26-213908.md) | [491](/filings/0001193125-26-340176.md) |
| Shareholders' equity | $m | [428](/filings/0000950170-24-123725.md) | [425](/filings/0001193125-26-081484.md) | [400](/filings/0001193125-25-272253.md) | [397](/filings/0001193125-25-272253.md) | [394](/filings/0001193125-25-272253.md) | [387](/filings/0001193125-26-340176.md) | [374](/filings/0001193125-26-340176.md) | [389](/filings/0001193125-26-340176.md) | [397](/filings/0001193125-25-272253.md) | [403](/filings/0001193125-26-340176.md) | [403](/filings/0001193125-26-340176.md) | [517](/filings/0001193125-26-340176.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.6 d](/filings/0000950170-24-123725.md) | [1.9 d](/filings/0001193125-26-081484.md) | [11.0](/filings/0000950170-25-067201.md) | [34.8 d](/filings/0000950170-25-105611.md) | [27.5 d](/filings/0001193125-25-272253.md) | [27.7 d](/filings/0001193125-26-081484.md) | [(4.7)](/filings/0001193125-26-213908.md) | [13.4 d](/filings/0001193125-26-340176.md) | [(8.6) d](/filings/0001193125-25-272253.md) | [22.9 d](/filings/0001193125-26-081484.md) | [17.1](/filings/0001193125-26-213908.md) | [24.4 d](/filings/0001193125-26-340176.md) |
| Capital expenditure | $m | [0.2 d](/filings/0000950170-24-123725.md) | [0.2 d](/filings/0001193125-26-081484.md) | [0.3](/filings/0000950170-25-067201.md) | [0.9 d](/filings/0000950170-25-105611.md) | [2.2 d](/filings/0001193125-25-272253.md) | [0.9 d](/filings/0001193125-26-081484.md) | [1.3](/filings/0001193125-26-213908.md) | [1.8 d](/filings/0001193125-26-340176.md) | [0.9 d](/filings/0001193125-25-272253.md) | [0.9 d](/filings/0001193125-26-081484.md) | [0.4](/filings/0001193125-26-213908.md) | [0.2 d](/filings/0001193125-26-340176.md) |
| Dividends paid | $m | [3.8 d](/filings/0000950170-24-123725.md) | [3.8 d](/filings/0001193125-26-081484.md) | [3.8](/filings/0000950170-25-067201.md) | [3.9 d](/filings/0000950170-25-105611.md) | [3.9 d](/filings/0001193125-25-272253.md) | [3.9 d](/filings/0001193125-26-081484.md) | [3.9](/filings/0001193125-26-213908.md) | [4.2 d](/filings/0001193125-26-340176.md) | [4.1 d](/filings/0001193125-25-272253.md) | [4.1 d](/filings/0001193125-26-081484.md) | [4.1](/filings/0001193125-26-213908.md) | [4.3 d](/filings/0001193125-26-340176.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [122](/filings/0000950170-23-063085.md) | [124](/filings/0000950170-24-056908.md) | [124](/filings/0000950170-24-094357.md) | [116](/filings/0000950170-24-123725.md) | [123](/filings/0000950170-25-067201.md) | [120](/filings/0000950170-25-105611.md) | [119](/filings/0001193125-25-272253.md) | [119](/filings/0001193125-26-213908.md) | [119](/filings/0001193125-26-340176.md) | [118](/filings/0001193125-25-272253.md) | [117](/filings/0001193125-26-213908.md) | [120](/filings/0001193125-26-340176.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.